 BOSTON and LAUSANNE, Switzerland, Feb. 16, 2022 GLOBE NEWSWIRE -- SOPHiA GENETICS SA Nasdaq: SOPH, a leader in data-driven medicine, today announced it will release its financial results for the fourth quarter and full year 2021 before U.S. markets open on Tuesday, March 15, 2022. SOPHiA will host a conference call and live webcast to discuss its financial results as well as business outlook beginning at 8:30 a.m. Eastern Time 2:30 p.m. Central European Time. 